Find a Clinical Trial
Filter
HER2 Negative Breast Cancer
Breast cancer
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Breast cancer
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
VAPOR 2
Prostate cancer
All genders
50-89
Recruiting now
Department of Urology
BCL Study
Breast cancer
Female
18+
Recruiting now
Department of Surgery